Exencial Wealth Advisors LLC Has $14.05 Million Stake in UnitedHealth Group Incorporated $UNH

Exencial Wealth Advisors LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 27.4% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 45,040 shares of the healthcare conglomerate’s stock after selling 16,962 shares during the period. Exencial Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $14,051,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the stock. Nabity Jensen Investment Management Inc raised its holdings in shares of UnitedHealth Group by 0.9% in the 1st quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock worth $1,446,000 after purchasing an additional 24 shares during the period. Atlantic Edge Private Wealth Management LLC raised its holdings in UnitedHealth Group by 8.9% during the 1st quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock valued at $160,000 after acquiring an additional 25 shares during the period. HHM Wealth Advisors LLC raised its holdings in UnitedHealth Group by 0.9% during the 1st quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after acquiring an additional 26 shares during the period. Brogan Financial Inc. increased its holdings in shares of UnitedHealth Group by 3.4% in the first quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate’s stock worth $429,000 after purchasing an additional 27 shares during the period. Finally, West Wealth Group LLC increased its holdings in shares of UnitedHealth Group by 3.2% in the first quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate’s stock worth $462,000 after purchasing an additional 27 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.3%

NYSE:UNH opened at $365.47 on Wednesday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a market cap of $331.00 billion, a PE ratio of 15.83, a price-to-earnings-growth ratio of 2.36 and a beta of 0.47. The company has a 50 day simple moving average of $333.70 and a two-hundred day simple moving average of $341.28.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. UnitedHealth Group’s payout ratio is 38.30%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Robert W. Baird reaffirmed an “underperform” rating and issued a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Bank of America increased their target price on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research note on Wednesday, October 8th. Piper Sandler cut their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Sanford C. Bernstein upped their price target on shares of UnitedHealth Group from $379.00 to $433.00 and gave the company an “outperform” rating in a research report on Wednesday, October 8th. Finally, UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Eighteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $385.13.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.